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Abstract
Systems biology is a rapidly evolving discipline that endeavours to understand the detailed
coordinated workings of entire organisms, with the ultimate goal to detect differences between
health and disease, or to understand how cells or entire organisms react to the environment. The
editorial provides a critical evaluation of what molecular systems analysis can and cannot
accomplish with existing methodologies, and how systems biology needs to merge with
reductionism to yield a more comprehensive and mechanistically insightful model of a cell or
organism.
Editorial
The recent few years have seen a growing interest in defin-
ing and establishing the emerging discipline of systems
biology. While it is difficult to clearly define such a rapidly
evolving discipline, characteristic trends are becoming
apparent that allow a definition of what systems biology
plans to accomplish. System biology endeavours to
understand the detailed coordinated workings of entire
organisms, with the ultimate goal to detect differences
between health and disease, or to understand how cells or
entire organisms react to the environment. Its ultimate
goal is to understand the dynamic networks of regulation
and interactions that allows cells and organisms to live in
a highly interactive environment, and to understand how
perturbations in the system cause disease.
Systems biology has been enabled by recent advances in
multi-disciplinary scientific disciplines that allow for the
parallel large-scale measurement of biomolecules, such as
mRNA, proteins and metabolites. Understanding the
detailed physiology of cells, tissues and entire organisms
afforded by this approach will lead to a more comprehen-
sive understanding of basic cellular events and their coor-
dination. This comprehensive investigative approach
represents a major shift in scientific paradigm, and over
time will clearly have a major impact on how scientific
analysis will be conducted.
The critics of systems biology are ready to point out that
"omic" approaches are not a substitute for hypothesis
driven research, because a systems analysis does not pro-
vide a testable hypothesis but is more akin a "fishing expe-
dition", yielding minable information of a collective of
molecules. However, this view-point does not do the dis-
cipline justice, because large scale investigative
approaches can be hypothesis driven. For instance, one
can form more global hypotheses such as a cell line or tis-
sue changes protein expression/modification patterns in
response to a drug stimulus, and that these changes are
causally related to a toxic response to the drug. Using inte-
grated molecular tools, these induced changes can readily
be measured and compared to an appropriate experimen-
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tal control. Cluster and correlation analysis of these data
will then readily describe the dynamics of molecular
changes in response to a perturbation of the system, in
this case a drug challenge. Taken at face value, this collec-
tive information will provide the researcher with a foun-
dation to create better-informed hypotheses. This then
accelerates the discovery process by avoiding the sequen-
tial trial and error approach that often plague classical
experimentation.
However, the inherent danger of current systems
approaches lies in the temptation to over interpret the
data and conclude predictions about mechanisms based
on experimentally unproven correlations. For example,
while it is easy to make pathway predictions by combin-
ing dynamic changes in cellular component concentra-
tion with prior knowledge about some (but not all)
proteins, it is impossible to derive mechanistic insights
from these data, because correlations alone cannot be
considered scientific proof of mechanisms. Additionally,
not all correlations are causally responsible for the pheno-
type of a cell or organism and can occur fortuitously.
The real question is what we wish to accomplish in mod-
ern biomedical research. Do we want to understand less
about more, using a systems biology approach to under-
stand global networks at the expense of mechanistic
detail, or do we go on understanding more about less,
using reductionist approaches aimed at understanding the
mechanistic details of molecular machineries at the
expense of comprehensive analysis. Both approaches
clearly have their strengths and limitations, depending on
what biological question needs to be answered. However,
to fully understand the workings of a biological system in
detail, both approaches need to be combined because
they provide complementary data. The real issue is that
high-throughput approaches, such as gene expression
analysis, proteomics (the quantification and identifica-
tion of proteins and their modifications), and metabo-
lomics (the quantification of metabolites) provide only
part of the cellular picture, namely the collective of mole-
cules in a cell. When comparing the dynamic changes in
molecular collectives between different experimental or
environmental conditions, correlations become obvious
that allow the generation of molecular or genetic net-
works of interdependence. While this information can
provide great insights into how genetic and proteomic
programs are modulated, the information alone does not
provide any mechanistic details of how these molecules
catalyze chemical reactions. The latter information can
only be obtained through reductionist approaches, for
example through the structural and functional analyses of
proteins and the reconstitution of biological processes in
vitro, which can scientifically prove function and mecha-
nism. Knowledge about tissue specific and subcellular
protein localization, together with quantitative informa-
tion about local or cellular abundance, will add further
detail that allows the interpretation and assessment of
which machineries are localized where and if a given
mechanism is likely to be significant to a particular proc-
ess.
Experimental data from system analysis and reductionist
approaches all have different formats. For example, vecto-
rial protein interaction maps are different from reaction
kinetic graphs. The key challenge in molecular systems
biology is therefore how to integrate the data from high-
throughput analyses with kinetic and mechanistic data
obtained through reductionism, which is needed for the
detailed description and modelling of cells and organ-
isms. The challenge is not only a technical one. The real
challenge lies in how to integrate both fields in a comple-
mentary fashion, and how to derive knowledge from data-
sets from vastly different disciplines in a meaningful
manner. The latter will bring along new challenges to the
bioinformatics community who will ultimately shift focus
from pure data mining approaches to approaches that
incorporate knowledge acquisition and determine cause-
effect relationships between pathways and molecules.
This experimental integration is more difficult, given the
vastly different strategies taken by both disciplines. For
the time being, high throughput approaches will yield a
more global image of cellular dynamics, which in many
cases can provide clues as to which pathway or molecules
to focus on for further reductionist investigation.
Often, systems biology is viewed as the "next trend" after
the genome project, suggesting it applies the knowledge
contained within the genetic code to an organism's phys-
iology. This statement implies that it might be as straight
forward as sequencing the genome to describe a system.
While the genome contains the blueprint of organisms
and a program of how to properly develop into one, the
description of the developmental and environmentally
responsive programs has many more dimensions and
requires us to understand the dynamics of how the collec-
tives of molecules in a cell and organism interact and at
what concentrations they are present in what specific
localization. This brings along challenges of how to pro-
vide the measurements to acquire the necessary data, how
to store and mine these data, and lastly how to efficiently
derive mechanistic insights. The challenge to describe and
model at the detailed systems level seems to be insur-
mountable from the technical perspective at this time.
However, it is worthwhile remembering that when the
human genome project firstly was proposed, many scep-
tics doubted that it would be technically feasible to
sequence and assemble a genome as complex. With time
and the appropriate resources spent, the next decade or
two will undoubtedly see major advances in the model-Publish with BioMed Central    and   every 
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ling of complex systems, as well as in the creation of more
mature technologies to detect, quantify, and functionally
analyse cellular and organismal constituents. Looking
even more into the future, it may well become possible to
extend systems analysis to individuals, thus describing
and perhaps predicting how such an individual may react
to the environment or to medications, the latter of which
is crucial for the development of personalized medicine.
Individuals can respond to a given drug treatment regime
in different ways, due to their distinct genetic make-up in
addition to having experienced distinct environments that
can coin a different physiology. It is therefore imperative
to measure the molecular physiology prior and immedi-
ately after drug exposure to link dynamic changes in
molecular composition to outcome therapeutic regimes
or that of disease. Finding molecular signatures or actual
biomarker that are predictive of disease or treatment out-
come is a first step into that direction, where an individual
systems analysis will ultimately help the care provider to
customize a treatment regime.
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